Alzheimer's Anti-Inflammation trial halted early – limited findings

NCT ID NCT04795466

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times

Summary

This study aimed to see if anti-inflammatory drugs could help people with early Alzheimer's disease or mild cognitive impairment. It included 34 participants and was stopped early, so only one drug was tested. The main goal was to measure changes in thinking and memory, but the early termination means we have limited information on whether these drugs work.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Massachusetts General Hospital

    Charlestown, Massachusetts, 02129, United States

  • Novartis Investigative Site

    Kuopio, 70210, Finland

  • Novartis Investigative Site

    Turku, 20520, Finland

  • Novartis Investigative Site

    Reykjavik, 101, Iceland

  • Novartis Investigative Site

    Plymouth, Devon, PL6 8BT, United Kingdom

  • Novartis Investigative Site

    Guildford, Surrey, GU27YD, United Kingdom

  • Novartis Investigative Site

    London, W1G 9JF, United Kingdom

  • Novartis Investigative Site

    Motherwell, ML1 4UF, United Kingdom

  • Novartis Investigative Site

    Southampton, SO30 3JB, United Kingdom

  • SUNY at Stony Brook

    Stony Brook, New York, 11794-8161, United States

Conditions

Explore the condition pages connected to this study.